About us
Founded in 2012 and granted the qualification of biomedicine company by the Ministry of Economic Affairs in 2015, Energenesis Biomedical Co., Ltd. aspires to become a new star in biotech industry.
Information
- 2026-02 Energenesis Biomedical Co., Ltd. Obtains Patent Grant in Canada for 'METHODS FOR TREATING DIABETIC ULCER' Following PCT National Phase Entry
- 2026-02 EB Receives a letter from the Ministry of Health and Welfare in which the Ministry has given its approval to conduct a Phase II IND clinical trial of F703EB
- 2025-12 Energenesis Biomedical Wins the 22nd Taiwan National Innovation Award
- 2025-11 Energenesis Biomedical Receives FDA Clearance for Phase II Trial of ENERGI-F703EB
- 2025-10 Energenesis Biomedical Announces IND Submission to the U.S. FDA for Phase II Clinical Trial of ENERGI-F703EB Cream